Anaconda Biomed
Anaconda Biomed develops funnel-shaped thrombectomy catheters that help neurointerventional physicians remove clots during treatment of large-vessel-occlusion stroke.
$56MSeries C
LeadOF
Omega Funds
Activity from announced rounds
All recorded activity
- Rounds participated in
- 5
- Confirmed lead rounds
- 1 4 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $364.5M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in all activityVaderis Therapeutics
Develops an oral AKT inhibitor for hereditary hemorrhagic telangiectasia
$152MSeries B
Role not disclosedThird Arc Bio
Develops novel multifunctional antibodies for oncology and immunology & inflammation indications
$52MSeries A+
Role not disclosedCaldera Therapeutics
Develops bispecific antibody CLD-423 for inflammatory bowel disease
$37.5MSeries A1
Role not disclosedSpiro Medical
Develops a Pulmonary Neuromodulation System for asthma treatment
$67MSeries A
Role not disclosed